Where does Addex Pharma, S.a. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Addex Pharma, S.a. ranks #20,684 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Addex Pharma, S.a. hold?

Addex Pharma, S.a. holds 13 US utility patents granted between 2015 and 2018, spanning 5 technology areas.

What is Addex Pharma, S.a.'s Innovation Score?

Addex Pharma, S.a. has an Innovation Score of 28.1 out of 100 (top 74% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Addex Pharma, S.a.'s patent grant rate increasing or decreasing?

Addex Pharma, S.a.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Addex Pharma, S.a.'s patents?

Addex Pharma, S.a.'s patents average 18.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Addex Pharma, S.a. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Addex Pharma, S.a.

Q: What technology areas does Addex Pharma, S.a. focus on?

Addex Pharma, S.a.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 13 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Addex ranks #20,684 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#20,684
of 50,000 US assignees by volume: Top 74%
by Innovation Score (28.1/100): 18.5
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20684 · Foreign Corporation #20,684 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #20,684/50,000
PHOTO-FINISH Accuenergy (Canada)
CPC-NARROW A61P · 5 areas
INNOV-THIN 28.1/100
CLAIMS-RICH 18.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Accuenergy (canada) Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Addex Pharma · this assignee

28
3D Lighting Innovati… · lowest

7

What this shows Addex's Innovation Score is 28.1/100 (top 74% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Addex's grants concentrate

Addex Pharma, S.a. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2015 (7 grants) versus a trough of 2 in 2016. By volume, Addex sits between Acleap Power Inc. and Advanced Cardiac Therapeutics, Inc..

Acleap Power

13
Accuweather

13
Accuenergy (Canad…

13
Aceaxis

13
Adlens Beacon

13
Advanced Aesthetic

13
Advanced Animal D…

13
Advanced Cardiac…

13
Addex Pharma ◀

13

What this shows Addex holds 13 patents at rank #20,744, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Addex

By rank, the assignees closest to #20,744 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Addex's primary technology class.

Addex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 Top 74% higher than 26% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Addex Pharma, S.a. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	53.8%
2016	2	15.4%
2017	2	15.4%
2018	2	15.4%

Which technologies does Addex Pharma, S.a. patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 13

C07D - HETEROCYCLIC COMPOUNDS 13

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 11

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#20,684

of 50,000 tracked assignees

Innovation Score

28.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.